Heme oxygenase (HO) exists as constitutive (HO-2, HO-3) and inducible isoforms (HO-1), the latter which responds to regulation by multiple stress-stimuli \[[@B1]\]. Several signaling molecules (e.g., mitogen-activated protein kinases), transcriptional regulators (activator protein-1, NF-E2-related factor-2, hypoxia-inducible factor-1, Bach-1), as well as two enhancer regions in the *ho-1* 5\' regulatory region, participate in the regulation of the *ho-1* gene \[[@B2]\]. Recent progress indicates that carbon monoxide (CO), a gaseous second messenger, exerts novel anti-inflammatory and anti-apoptotic effects (Table [1](#T1){ref-type="table"}), although little is known about the precise molecular mechanism of these actions. There has been many reports that inhalation of CO could be protective against acute ischemia-reperfusion injury in intestine, lung, kidney, and liver (Table [2](#T2){ref-type="table"}). More recent report indicates that inhalation of 100--125 ppm CO by patients with chronic obstructive pulmonary disease is feasible and leads to trends in reduction of sputum eosinophils and improvement of responsiveness to methacholine \[[@B3]\]. In addition to beneficial effects of CO, further studies need to confirm the safety of this gas, especially in the cardiac function \[[@B4], [@B5]\]. In this serial review, we invited several outstanding researchers in this field to summarize their work, to review their peers' activity, and to encourage us their opinions. I thank all the anonymous reviewers of these articles for their insightful comments.

###### 

Mechanisms of anti-inflammatory and cytoprotective effects of carbon monoxide

  --------------------------------------------------------------------
  Inhibition of chemokines and chemokine receptors
  Inhibtion of ICAM-1
  Inhibition of iNOS expression and NO production
  Inhibition of Th1 type cytokines (IL-2, IFNγ)
  Inhibition of proinflammatory mediators (IL-1β, TNFα, IL-6, COX-2)
  Augmentation of IL-10
  Heme oxygenase-1-dependent pathway
  Nuclear factor-κB-independent pathway
  Soluble guanylyl cyclase (sGC)-dependent pathway
  p38MAPK pathway-dependent
  Akt-eNOS pathway-dependent
  --------------------------------------------------------------------

###### 

Effects of inhalated carbon monoxide on experimental disease models in rodents

  Animal   Organ            Model                          Carbon monoxide   Efficacy                 Year        Authors   
  -------- ---------------- ------------------------------ ----------------- ------------------------ ----------- --------- ----------------------
  Rat      Lung             Hyperoxic injury               250 ppm           56 h                     Effective   1999      Otterbein *et al.*
  Mouse    Lung             Inflammation by aeroallergen   250 ppm           48 h                     Effective   2001      Chapman *et al.*
  Rat      Lung             Hyperoxic lung injury          50--500 ppm       60 h                     No change   2001      Clayton *et al.*
  Rat      Intestine        Ischemia/Reperfusion           250 ppm           1 h                      Effective   2003      Nakao *et al.*
  Rat      Intestine        Graft motility                 250 ppm           25 h                     Effective   2003      Nakao *et al.*
  Mouse    Intestine        Postoperative ileus            250 ppm           24 h                     Effective   2003      Moore *et al.*
  Mouse    Lung             Airway Hyperesponsiveness      250 ppm           1 h/day, 5 day           Effective   2003      Ameredes *et al.*
  Rat      Heart            Ischemia/Reperfusion           1000 ppm          30 min                   Effective   2004      Fujimoto *et al.*
  Rat      Kidney           Ischemia/Reperfusion           250 ppm           25 h                     Effective   2004      Neto *et al.*
  Mouse    Lung             Acute injury, ARDS             500 ppm           1 h                      No change   2005      Ghosh *et al.*
  Rat      Liver            Ischemia/Reperfusion           100 ppm           25 h                     Effective   2005      Kaizu *et al.*
  Rat      Intestine        Necrotizing enterocolitis      250 ppm           1h/day, 3day             Effective   2005      Zuckerbraun *et al.*
  Mouse    Multiple organ   Hemorrhagic shock              250 ppm           1 h                      Effective   2005      Zuckerbraun *et al.*
  Rat      Intestine        Postoperative ileus            250 ppm           24 h                     Effective   2005      Moore *et al.*
  Mouse    Intestine        IL-10-deficient colitis        250 ppm           24 h                     Effective   2005      Hegazi *et al.*
  Rat      Heart            Myocardial infarction          500 ppm           3 week                   Worse       2005      Mirza *et al.*
  Mouse    Liver            Ischemia/Reperfusion           250 ppm           1 h                      Effective   2005      Ott *et al.*
  Pig      Lung             Endotoxin shock                250 ppm           1 h                      Effective   2005      Mazzola *et al.*
  Rat      Heart            Allograft survival             20 ppm            14--100 days             Effective   2006      Nakao *et al.*
  Rat      Kidney           Allograft nephrophathy         20 ppm            30 days                  Effective   2006      Neto *et al.*
  Rat      Lung             Donors/recipients              250 ppm           pre (1 h)/after          Effective   2006      Kohmoto *et al.*
  Rat      Heart            Dysfunction/hypoxia            100 ppm           90 min                   Worse       2006      Favory *et al.*
  Swine    Vein             Intinal hyperplasia            100/250 ppm       pre/intraope.            Effective   2007      Ramlawi *et al.*
  Mouse    Liver            Fulminant hepatitis            250 ppm           1 h                      Effective   2007      Tsui *et al.*
  Rat      Heart            Dysfunction/hypoxia            50 pm             1 week                   Worse       2007      Gautier *et al.*
  Rat      Lung             Ischemia/Reperfusion           250 ppm           2 h                      Effective   2007      Boutros *et al.*
  Rat      Multiple organ   LPS-induced MOF                250 ppm           3 h                      Effective   2007      Liu *et al.*
  Rat      Liver            Transplantation                20--250 ppm       pre (1 h)/after (24 h)   Effective   2007      Kaizu *et al.*
